VBI Vaccines Inc.

NASDAQ:VBIV   3:59:58 PM EDT
2.86
+0.12 (+4.38%)
Products

VBI Vaccines Announces Submission of Biologics License Application to FDA for 3-Antigen Prophylactic Hepatitis B Vaccine

Published: 12/01/2020 13:08 GMT
VBI Vaccines Inc. (VBIV) - Vbi Vaccines Announces Submission of Biologics License Application to FDA for 3-antigen Prophylactic Hepatitis B Vaccine.